- Tytuł:
- Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
- Autorzy:
- Źródło:
- In The Lancet Oncology June 2019 20(6):849-861
Czasopismo naukowe